Antibacterial activity of DL 473, a C3-substituted rifamycin derivative.
AUTOR(ES)
Neu, H C
RESUMO
DL 473 is a 3-[(4-cyclopentyl-1-piperazinyl)iminomethyl] rifamycin SV derivative which inhibited staphylococci, streptococci (including Streptococcus faecalis, Listeria species, and Bacteroides species. DL 473 was less active than rifampin against these species. DL 473 did not inhibit Enterobacteriaceae nor most Pseudomonas species. A combination of DL 473 and vancomycin or nafcillin tested against staphylococci was primarily additive and antagonism was not encountered.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=185348Documentos Relacionados
- Comparison of concentrations of rifampin and a new rifamycin derivative, DL 473, in canine bone.
- Antibacterial activity of GO 10213, a nitroimidazole derivative.
- In vitro and in vivo activity of DL-8280, a new oxazine derivative.
- Inhibition of infectious Rous sarcoma virus production by rifamycin derivative.
- In vitro and in vivo antibacterial activity of AM-833, a new quinolone derivative.
